Show items per page
Elements: 4
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients Bruggmann, P.; Falcato, L.; Dober, S.; Helbling, B.; ... Meili, D. 2008
add to browser selection
Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation Dinges, S.; Morard, Isabelle; Heim, M.; Dufour, J-F; ... Negro, Francesco 2009
add to browser selection
The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients Boursier, J; Ducancelle, A; Vergniol, J; Veillon, P; ... De Lédinghen, V 2015
add to browser selection
Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes Testoni, Barbara; Durantel, David; Lebossé, Fanny; Fresquet, Judith; ... Zoulim, Fabien 2016